Oxygenated albumin for use as blood and blood extender

Details Oxygenated albumin for use as blood and blood extender Oxygenated albumin for use as blood and blood extender

2007-06-12

2007-06-12

Wax, Robert A. (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S613000, C530S363000, C530S367000

Reexamination Certificate

active

10987787

ABSTRACT:
The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to O2saturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in concentrations from about 5% w/v to about 25% w/v, are useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood.

REFERENCES:
patent: 4439424 (1984-03-01), Ecanow et al.
patent: 5948609 (1999-09-01), Carter et al.
patent: 6770052 (2004-08-01), Hill et al.
PCT International Search Report by the European Patent Office for International Application No. PCT/US2005/034797 dated Jun. 2, 2006 (3 pages).
“Secretion of Medullipin I by Isolated Kidneys Perfused Under Elevated Pressure” Clinical and Experimental Pharmacology and Physiology, by E. E. Muirhead et al., vol. 18, No. 6, Jun. 1991 (pp. 409-417).

Affiliated with

Also associated with

Rating

Oxygenated albumin for use as blood and blood extender does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxygenated albumin for use as blood and blood extender, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxygenated albumin for use as blood and blood extender will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3883832